FDA Inspection 1074982 — Emory University Hospital Midtown- Center for Transfusion & Cellular Therapies
The FDA completed an inspection of Emory University Hospital Midtown- Center for Transfusion & Cellular Therapies on November 30, 2018 in Atlanta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 30, 2018
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Atlanta, GA (United States)